|
OTCMarketbulls.com Brings You the HOTTEST gainers! Sign Up Today!! ALTI +29.65%, YRCW +22.91%, TIBX +12.34%, HLCS +20.87%
(M2 PressWIRE Via Acquire Media NewsEdge) OTCMarketbulls.com Presents: Altair Nanotechnologies (NASDAQ: ALTI), YRC Worldwide (NASDAQ: YRCW), TIBCO Software (NASDAQ: TIBX), Helicos BioSciences Corporation (NASDAQ: HLCS)
To sign up for our free Profiles & Alerts :: visit http://www.otcmarketbulls.com
Also find out daily volume movers on twitter: www.twitter.com/otcmarketbulls
------------------------------------------------------------------------------------------------------------------------------------------------------------
ALTI LATEST NEWS
Altairnano Granted Patent for Nanotechnology Manufacturing Process Manufacturing Process Expands Intellectual Property Protection for Battery Anode and Cathode Designs
RENO, NV--(06/25/10) - Altair Nanotechnologies, Inc. (Altairnano) (NASDAQ:ALTI - News), announced it had been granted a U.S. patent for the "Method of Producing Mixed Metal Oxides and Metal Oxide Compounds." This patent protects the unique nanotechnology manufacturing process for battery anodes and cathodes in lithium-ion batteries utilizing a wider range of metal oxides.
"This patent enhances our intellectual property portfolio and further establishes an important competitive advantage for Altairnano," said Terry M. Copeland, Altairnano's President and Chief Executive Officer. "The patent creates an important barrier to entry as we focus on the development of cathode materials to enhance battery performance at lower costs. Competitors will be unable to utilize the proprietary manufacturing process covered under the patent to achieve the unique performance characteristics of rapid charging and discharging over the wide operating temperature range of our battery materials."
About Altair Nanotechnologies Inc.
Headquartered in Reno, Nevada with manufacturing in Anderson, Indiana, Altairnano is a leading provider of energy storage systems for clean, efficient power and energy management. Going beyond lithium ion, Altairnano's Lithium-Titanate based battery systems are among the highest performing and most scalable, with applications that include complete energy storage systems for use in providing frequency regulation and renewables integration for the electric grid, battery modules and cells for mass transit applications, and battery packs for several different military applications. For more information please visit Altairnano at http://www.altairnano.com/.
------------------------------------------------------------------------------------------------------------------------------------------------------------
YRCW LATEST NEWS
YRC Worldwide Announces Definitive Agreement for Austin Ventures to Acquire YRC Logistics YRC Worldwide continues to benefit from global logistics services through partnership with new company OVERLAND PARK, Kan., June 25 -- YRC Worldwide Inc. (Nasdaq:YRCW - News) today announced it has entered into a definitive agreement to sell a portion of its YRC Logistics business to Austin Ventures, a strategic private equity investor. This logistics business will operate as a private company owned by Austin Ventures. The sale will form the basis for a new company specializing in international freight forwarding, customs brokerage, transportation management, truckload services, and dedicated warehouse and fulfillment services in North America, Latin America, Europe and Asia.
"This transaction enables YRC Worldwide to focus on our core transportation capabilities while continuing to offer full global logistics solutions for our customers through a strong business relationship with the new company," says Bill Zollars, chairman, president and CEO, YRC Worldwide. "There will be no change in the way a customer's business is handled, and they will benefit from advancements in the delivery of comprehensive supply chain solutions by both companies. In addition, the incremental liquidity from the transaction will support YRC Worldwide business growth."
YRC Worldwide will retain all of its China-based operations and the strategic partnership with Austin Ventures gives customers of the new logistics company ongoing access to these capabilities.
"We are very pleased to partner with the management team of YRC Logistics. We see opportunities to invest in the company and position it for growth through expanded offerings and the continued expansion of its global network," says David Lack, partner, Austin Ventures. "This investment builds on Austin Ventures' commitment to work alongside talented executive teams in leading, high-growth supply chain services companies."
"The current YRC Logistics management team remains in place and customers will experience the same expertise and accountability," adds John Carr, president-YRC Logistics. "The substantial equity infusion from Austin Ventures positions us to pursue new business development as well as growth through acquisition."
The agreement between YRC Worldwide and Austin Ventures is for an acquisition price of $37 million, and incremental value will be realized by both parties through a comprehensive commercial services agreement. The transition to new ownership is expected to be complete within the next 30-45 days.
About Austin Ventures
Austin Ventures ("AV") has worked with talented entrepreneurs to build valuable companies for over twenty-five years. With $3.9 billion under management, AV is the most active venture capital and growth equity firm in Texas and one of the most established in the nation. With an investment focus on business services and supply chain, financial services, media and information services, software and Internet, and Texas special situations, AV invests at all stages of company development, from $100,000 in "planned experiments" in early stage ideas to $100+ million investments in expansion rounds, minority recapitalizations, and buyouts of lower middle market growth companies. AV has been an active investor in the transportation and logistics sector - including current investments in port-based warehousing and distribution, truck and intermodal brokerage, and returns management solutions - and continues to actively expand its presence in the space. AV's strategy is to partner with talented executives and entrepreneurs through its CEO-in-Residence and Entrepreneur-in-Residence programs. Visit austinventures.com for more information.
About YRC Worldwide
YRC Worldwide Inc., a Fortune 500 company headquartered in Overland Park, Kan., is one of the largest transportation service providers in the world and the holding company for a portfolio of successful brands including YRC, YRC Reimer, YRC Glen Moore, New Penn, Holland and Reddaway. YRC Worldwide has the largest, most comprehensive network in North America with local, regional, national and international capabilities. Through its team of experienced service professionals, YRC Worldwide offers industry-leading expertise in heavyweight shipments and flexible supply chain solutions, ensuring customers can ship industrial, commercial and retail goods with confidence. Please visit http://www.yrcw.com/ for more information.
------------------------------------------------------------------------------------------------------------------------------------------------------------
TIBX LATEST NEWS
TIBCO Software Grows License Revenue by 23% and Total Revenue by 21% Over Q2 2009 Non-GAAP EPS Increases to $0.15 PALO ALTO, CA--(06/24/10) - TIBCO Software Inc. (NASDAQ:TIBX - News) today announced results for its second quarter, which ended on May 30, 2010.
Total revenue for the second quarter of fiscal 2010 was $173.3 million and net income was $12.8 million, or $0.08 per diluted share. This compares to total revenue of $142.7 million and net income of $10.1 million, or $0.06 per diluted share, as reported for the second quarter of fiscal 2009.
On a non-GAAP basis, net income for the second quarter of fiscal 2010 was $26.2 million or $0.15 per diluted share, compared with $19.0 million or $0.11 per diluted share for the second quarter of fiscal 2009. Non-GAAP operating income for the second quarter of fiscal 2010 was $38.8 million, an increase of 43% over non-GAAP operating income of $27.1 million in Q2 2009. This implies an expansion of non-GAAP operating margins of 340 basis points, from 19.0% in Q2 2009 to 22.4% in Q2 2010. Non-GAAP results exclude stock-based compensation expense, amortization of acquired intangible assets, restructuring expenses, and acquisition related and other expenses and assume non-GAAP effective tax rates of 31% and 32% for the second fiscal quarters of 2010 and 2009, respectively.
"Our business continued its strong momentum in Q2, delivering accelerated growth in license revenue, total revenue, and operating profits," said Vivek Ranadive, TIBCO's chairman and chief executive officer. "Our core SOA business grew 34% over last year, our BPM business delivered a major new product release, and our Business Optimization technologies continue to drive deals for us. Customers from all industries are embracing our event-driven and in-memory products to help achieve their Two-Second Advantage, and we have the products, solutions and expertise to help them get there."
Second Quarter Fiscal 2010 Highlights
-- Total revenue increased 21% year over year to $173.3 million;-- License revenue increased 23% year over year to $62.1 million;-- Non-GAAP operating margin was 22.4%;-- Cash flow from operations was $41.0 million;-- Repurchased 3.4 million shares;-- Diverse mix of business across major industries including Financial Services, Telecommunications, Energy, Government, Life Sciences, and Insurance;-- TIBCO closed 85 deals over $100k and had 12 deals over $1 million; and-- TIBCO expanded its business with leading companies and agencies in the second quarter such as The City of Anaheim, Corinthian Colleges, Sydney Water Corporation, TeliaSonera, Telkom, Telstra, Total Systems Services, and Vodafone.
Conference Call Details
TIBCO has scheduled a conference call for 4:30 pm ET / 1:30 pm PT today to discuss its second quarter results. The conference call will be hosted by InterCall and may be accessed over the Internet at http://www.tibco.com/ or via dial-in at (877) 293-9114 or (706) 758-2055. Please join the conference call at least 10 minutes early to register. A replay of the conference call will be available until midnight on July 24, 2010 at http://www.tibco.com/ or via dial-in at (800) 642-1687 or (706) 645-9291. The pass code for both the call and the replay is 78422894.
About TIBCO
TIBCO's technology digitized Wall Street in the '80s with event-driven "Information Bus" software, which helped make real-time business a strategic differentiator in the '90s. Today, TIBCO's infrastructure software gives customers the ability to constantly innovate by connecting applications and data in a service-oriented architecture, streamlining activities through business process management, and giving people the information and intelligence tools they need to make faster and smarter decisions, what we call The Power of Now . TIBCO serves more than 3,000 customers around the world with offices in more than 20 countries and an ecosystem of over 200 partners. Learn more at http://www.tibco.com/.
TIBCO, The Power of Now and TIBCO Software are trademarks or registered trademarks of TIBCO Software Inc. in the United States and/or other countries. All other product and company names and marks mentioned in this document are the property of their respective owners and are mentioned for identification purposes only.
------------------------------------------------------------------------------------------------------------------------------------------------------------
HLCS LATEST NEWS
Helicos BioSciences Announces Launch of Diagnostics Business CAMBRIDGE, Mass.--(6/25/10)--Helicos BioSciences Corporation (NASDAQ: HLCS - News) announced today that it is in the early stages of validating molecular diagnostic (MDx) tests that utilize its HeliScope Single Molecule Sequencer. The HeliScope Sequencer's ability to sequence single molecules of natural, unamplified DNA or RNA simplifies the diagnostic testing workflow obviating the need for the amplification steps utilized by most genetic analysis methods. This ability to eliminate amplification steps has several advantages including the potential for Helicos to sell its MDx tests for substantially less than the price of comparable existing diagnostic tests.
"Our plan to develop and market our own MDx tests is driven by our confidence in the unique capabilities of the HeliScope Sequencer," stated Ron Lowy, President and Chief Executive Officer. "Over the past months, we have considered a number of alternatives to our long-term strategic focus and consulted with industry experts, many of whom shared our confidence in the HeliScope Sequencer. Ultimately, we decided developing tests for the nascent and expanding diagnostics sequencing market presented the best opportunity to deploy technology that will potentially drive rapid near term revenue growth by providing attractively priced MDx tests."
Helicos believes that the HeliScope Sequencer will have utility across a broad array of MDx tests. Initially, Helicos is developing a MDx test that will identify gene mutations indicative of a woman's increased risk of developing hereditary breast or ovarian cancer. This test is currently scheduled to launch during the second quarter of 2011.
Helicos is also developing additional MDx tests in well-established markets. Helicos intends over the longer term to use its core technology's quantitative capabilities to explore developing MDx tests based upon the detection and quantification of foreign DNA/RNA circulating in the bloodstream, such as a non-invasive prenatal diagnostic test.
In furtherance of its new strategic plan, Helicos has begun development of its own genetic testing laboratory for which it expects to seek certification under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). In connection with this, Helicos recently hired Dr. Robert Wassman as Chief Medical Officer (CMO). Dr. Wassman has over 25 years of experience in the clinical translation of innovative genetic testing technologies, and has held a variety of professional and senior management positions. Most recently, he was a Founder and CMO of Good Start Genetics, a company focused on the application of "Next Generation" DNA sequencing to assess individual carrier status for rare genetic disorders. Previously, he was President of Celula, Inc., which developed instruments for the isolation and analysis of rare, highly informative cells for personalized diagnostics. Prior to these start-up ventures, he was the Vice President and National Medical Director of Genzyme Genetics, where he held operational responsibility for all clinical services and genetic counseling, and also led business development and new product implementation for their reproductive franchise.
Additional information can be found in Helicos' Annual Report on Form 10-K for the fiscal year ended December 31, 2009, as filed with the SEC on April 15, 2010, together with its Quarterly Report on Form 10-Q for the first fiscal quarter 2010, as filed with the SEC on May 17, 2010. These reports include a discussion regarding the company's need to raise capital to pursue this new business of developing molecular diagnostic tests, disclosures regarding the company's operational results and liquidity position, and additional disclosures regarding other risks and uncertainties faced by Helicos.
About Helicos BioSciences:
Helicos BioSciences is a life science company focused on innovative genetic analysis technologies for the development and marketing of MDx tests. Helicos' proprietary True Single Molecule Sequencing (tSMS)TM technology allows direct measurement of billions of strands of DNA enabling the delivery of competitive MDx tests at lower price points than current tests. The company's corporate headquarters are located at One Kendall Square, Building 700, Cambridge, MA 02139, and its telephone number is (617) 264-1800. For more information, please visit http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.helicosbio.com&esheet=6340608&lan=en-US&anchor=www.helicosbio.com&index=1&md5=6276142b76485b7c81f4a48afd687131.
------------------------------------------------------------------------------------------------------------------------------------------------------------
OTCMarketbulls.com is an online financial destination where money managers, analysts, and individual investors can converge to discover new and exciting investment news, opportunities, and ideas. OTCMarketBulls.com is focused on finding emerging growth companies that do not necessarily have widespread analyst coverage on Wall Street. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by OTCMarketBulls.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed.
For full disclaimer/disclosure: http://www.otcmarketbulls.com/disclaimer.php
Visit Us On Twitter and Facebook: http://twitter.com/otcmarketbulls http://www.facebook.com/otcmarketbulls
SIGN UP FOR OUR FREE NEWSLETTER AND FREE EMAIL ALERTS!! http://www.otcmarketbulls.com
((Comments on this story may be sent to info@m2.com))
(c) 2010 M2 COMMUNICATIONS
[ Back To IP Communications Global Community's Homepage ]
|
TMCnet LOGIN
Webinars
